Agn nyse stock quote

Allergan plc - TheStreet - Stock Market Allergan Receives FDA Approval For DURYSTA™ (bimatoprost Implant) The First And Only Intracameral Biodegradable Sustained-Release Implant To Lower Intraocular Pressure In Open-Angle Glaucoma Or Allergan plc Stock Quote: AGN Stock News, Quotes, Analysis ...

Stable Share Price: AGN has not had significant price volatility in the past 3 months. Did Allergan plc (NYSE:AGN) Insiders Buy Up More Shares? 9 months   Latest Allergan plc (AGN:NYQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. 10 Feb 2020 The average price target among the 11 analysts covering the stock is $188, suggesting 4.7% downside from current levels. © 2020 Benzinga.com  Allergan PLC | 5.500% Mandatory Convertible Preferred Shares, Series A information page, at Preferred Stock Conversion Price: $288 to $352.80. Shares 

AGN Stock Quote of Allergan Plc

AGN: Get the latest Allergan stock price and detailed information including AGN news, historical charts and realtime prices. Allergan Plc - AGN - Stock Price Today - Zacks View Allergan Plc AGN investment & stock information. Get the latest Allergan Plc AGN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. AGN - Allergan Plc Stock Price - Barchart.com It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share. Allergan plc. (AGN) Dividend Date & History - Nasdaq

Feb 10, 2020 · Check out our AGN stock analysis, current AGN quote, charts, and historical prices for Allergan Plc stock. (NYSE:AGN) to April 10 from March 27.The consummation of the debt exchange i

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products. Exchange: NYSE. Stock analysis for Allergan PLC (AGN:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile. AGN: Get the latest Allergan stock price and detailed information including Allergan (AGN) Stock , NYSE. 178.15. 2.44. (1.39%). Official Close 4/6/2020. NYSE. AGN:NYSE. Real Time Quote | NYSE | USD. Extended Hours. Last Yield | 04/07/ 2020 Shares Outstanding 329.0M. Beta 1.30. Dividend (Yield) 2.96 (1.66%). Allergan plc Ordinary Shares (AGN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Analyzing Allergan (NYSE:AGN) stock? View AGN's stock price, price target, dividend, earnings, financials, forecast, insider trades, news, and SEC filings at 

View Allergan plc's fair value, stock price, financial statements, news, valuation NYSE:AGN. Financials. Exchange Data. 173.00 USD. Price. -2.54 (-1.45%).

Allergan plc : AGN Stock Price Quote at Ally Invest Free current stock price quotes and data for Allergan plc (AGN). Research news, charts, stock market performance and earnings. Quotes Snapshot > AGN. Allergan plc AGN:NYSE. Set Alert Options Streaming Charts. Last Price $174.90 NYSE Closing Price as of 6:30PM ET 4/01/20. Today's Change-2.20 (1.24%) Bid (Size) $158.40 (4)

View the latest Allergan PLC (AGN) stock price, news, historical charts, analyst ratings and financial information from WSJ.

NYSE Combining the high performance of NYSE Pillar technology with a taker/maker fee schedule. Learn about the NYSE Closing Auction. Trade Our Options & Bonds Markets. NYSE American Options. Offering traders deep liquidity across listed option contracts. Note: Quote Data is Delayed At Least 15 Minutes. AGN: Allergan plc - Stock Price, Quote and News - CNBC

Learn about AGN with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on AGN. Allergan (NYSE:AGN) - Share price, News & Analysis ... Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company operates in three segments: US Specialized Therapeutics, US General Medicine, and International.